Manuela Dorado Novoa

Biographic Data

ID9066261
NAMEManuela Dorado Novoa
GIVEN NAMESManuela Dorado
FAMILY NAMENovoa
SIGNATURENOVOA M D
AFFILIATIONSJohns Hopkins University
ORCID0009-0002-3371-8468
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2026
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Nearly one in five essential medicines fail quality standards in Africa

    Open AccessJean Christophe Rusatira, Manuela Dorado Novoa et al.ARTICLEPLOS Global Public Health2026

    Substandard and falsified (SF) medicines pose a major threat to maternal, newborn, and child health (MNCH) and malaria control in Africa, yet their true burden remains uncertain. We conducted a systematic review and meta-analysis of studies published between 2010 and 2025 that chemically tested the quality of essential MNCH and antimalarial medicines collected in African countries. Following PRISMA 2020 guidelines and a registered PROSPERO protoc…

  • Effectiveness of a Community Health Worker-Delivered Depression Intervention for Uninsured Latine Immigrants

    Open AccessMayra L Sanchez Gonzalez, Monica Guerrero Vazquez et al.ARTICLEJournal of Community Health2026

  • Tiered manufacturing of pharmaceuticals as a commercial determinant of health

    Open AccessJean Christophe Rusatira, Eishita Pal et al.ARTICLEPLOS Global Public Health2026

    Tiered manufacturing, the practice of adapting different levels of pharmaceutical production standards to low- and middle-income countries (LMICs) versus high-income countries, has not been investigated as a commercial determinant of health (CDoH), defined by the World Health Organization as a private sector activity affecting public health. This paper examines this practice and its implications for medicine quality, universal health coverage, an…